QA: Biodelivery Sciences International INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001103021_2022_Biodelivery_Sciences_International_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001103021, Biodelivery Sciences International INC

  xvar xval
0 AssetsCurrent 202,065,000
1 IntangibleAssetsNetIncludingGoodwill 2,715,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 119,816,000
4 LiabilitiesCurrent 82,378,000
5 LiabilitiesNoncurrent 219,000
6 remainder_Liabilities 54,177,000
7 CostOfGoodsAndServicesSold 21,856,132
8 SellingGeneralAndAdministrativeExpense 114,563,732
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses -332,267,304
11 remainder_Revenues 167,111,745
12 remainder_NetIncome -7,311,883
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 324,596,000
1 Liabilities 136,774,000
2 Expenses -195,847,440
3 Revenues 167,111,745
4 StockholdersEquity 187,822,000
5 NetIncome 355,647,302
6 ComprehensiveNetIncome 355,647,302
7 BaseVar 415,820,534
8 EconomicCapitalRatiobeforeLimitedLiability 3.32
9 EconomicCapitalRatio 3.90

Edgar->Model Mapping

Feature Distribution

Change over Time